Cutting edge research at the MAYO Clinic is leading to new hope for individuals with HLHS Heart Syndrome and cord blood is a critical part of the story. Can cord blood strengthen the heart? Join us on “Share the Science” to hear Dr. Timothy Nelson discuss his latest clinical trial.
Free Webinar: Save the Cord Foundation and Mediware, Inc. are proud to welcome Dr. Timothy Nelson for our next edition of Share the Science on May 17th, 2017. Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this enlightening presentation.
Imagine the news. . . you are pregnant or perhaps just gave birth and your doctor tells you that your baby’s heart has not developed correctly. It is HLHS. Treatment typically involves a series of three intense surgeries as soon as the baby is born. If left untreated, HLHS is fatal soon after birth.
What is HLHS?
HLHS or Hypoplastic Left Heart Syndrome is a rare and complex congenital heart defect for which there is currently no cure. Affecting more than 2,000 newborns in the United States each year, this disease is defined by underdevelopment. According to the Mayo Clinic, “In HLHS, the left side of a child’s heart — the left ventricle, ascending aorta and left heart valves — is severely underdeveloped. The result is a heart with only a single functional ventricular chamber — the right ventricle — and a small ascending aorta.” (Source: Mayo Foundation for Medical Education and Research (MFMER))
At the MAYO Clinic, Dr. Timothy Nelson, M.D., Ph.D. leads an innovative team of physicians and scientists with one goal in mind. . . find a cure for HLHS. As the director of Mayo Clinic’s Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, and the the medical director of the Regenerative Medicine Consult Service, Dr. Nelson and his team are pursuing an innovative clinical trial using stem cells from cord blood to strengthen a baby’s heart following a HLHS diagnosis. The umbilical cord blood cells are processed in a specific manner in order to create highly concentrated stem cells that are injected into the heart at the time of the baby’s second open heart surgery.
The HLHS program has also recently created the HLHS consortium, a network of institutions that are participating in HLHS research. The consortium makes it easier for patients to participate in the overall research, including the umbilical cord blood collection, no matter their location.
Join us for this special presentation. . .
Dr. Timothy NELSON
from the Mayo Clinic’s
Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome
“Strengthening the HLHS Heart Using Umbilical Cord Blood”
Wednesday, May 17 | 2 p.m. – 3 p.m. Central Time
Free to register. Open to the public.
In this webinar, you will learn:
- The importance of banking umbilical cord blood for babies with HLHS
- What makes Mayo Clinic’s Todd and Karen Wanek Family Program for HLHS unique when it comes to umbilical cord blood banking
- Details about the clinical trial using umbilical cord blood for babies with HLHS
- How HLHS research at Mayo Clinic’s HLHS program is changing the future for HLHS individuals
Want to learn more?
Share the Science continues to be a popular series within the cord blood community and beyond. We welcome your input on the series and suggestions for future speakers. Give your feedback here.
Share the Science is made possible thanks to the generous support of Mediware, Inc.